MKI67 and breast carcinoma: The second outcomes are clinicopathological parameters in breast cancer including the following items: histological grade; lymph node metastasis; The TNM classification of malignant tumors stage; the expression of HER-2, EGFR, estrogen receptor, PR, MKI67, cytokeratin 5/6.